Delivery Order SPE2DR25D3801-SPE2DR26F6QEB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Lyrica 300 mg capsules (90-count units) with a ceiling value of $1,713.51. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Lyrica 100 mg capsules (90-count units) valued at $2,530.67. This firm fixed-price delivery order, which is set to be completed by September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was awarded competitively with no set-aside designation, and the...
- The Defense Logistics Agency awarded a delivery order valued at $1,144.62 to AmerisourceBergen Drug Corp for the supply of Lyrica 75 mg capsules (90-count units) on November 24, 2025, with a completion date of November 25, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,336.03 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,119.78 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on December 16, 2025, with completion expected by December 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lyrica 100 mg capsules (90-count units) at a ceiling value of $1,260.77. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for ultimate completion by August 1, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lyrica 100 mg capsules (quantity: 90 units) with a ceiling value of $2,514.26. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract is scheduled for ultimate completion on...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Lyrica 225 mg capsules (90-count units) with a ceiling value of $1,180.72. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award is non-set-aside and was competitively awarded, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (unit dose, 100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with a ceiling value of $1,128.56 and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lyrica 200 mg capsules (90-count units) under a firm fixed-price contract with a ceiling value of $3,427.94. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 billion and extending through December 2026. The delivery is scheduled for completion by August 12,...
- SPE2DR25D3801Indefinite Delivery Contract
- SPE2DR25D3801-SPE2DR26F6QEBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Lyrica 25 mg capsules (90-count units) valued at $1,758.84. This firm fixed-price delivery order, with an ultimate completion date of December 16, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was not designated as a set-aside contract and was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its comprehensive DLA contract vehicle. The Lyrica supply order reflects AmerisourceBergen's role in delivering neurological treatment medications and other pharmaceutical products across multiple therapeutic domains to support military healthcare programs. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements through competitive processes, ranging from small-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/14/25 |